Plasmodium falciparum malaria causes half a million deaths per year, with up to 9% 28 of this mortality caused by cerebral malaria (CM). One of the major processes 29 contributing to the development of CM is an excess of host inflammatory cytokines. 30
Introduction 39 40
Plasmodium falciparum malaria is a major cause of mortality worldwide, causing an 41 estimated 219 millions cases and 435,000 deaths in 2018 1 . One of the most severe and 42 lethal complications of P. falciparum infection is the sudden onset of seizures and/or 43 coma, known as cerebral malaria (CM). Its occurrence varies from region to region, 44 with a case fatality rate as high as 9% of severe malaria cases in some areas 2, 3 . The 45 causes of CM are not well understood, but hypotheses include the accumulation of 46 parasitized red blood cells in the brain microvasculature, as well as imbalance in the 47 pro-and anti-inflammatory responses to infection 4 . 48
In recent years, potassium (K+) signaling has emerged as an important mediator of 50 the immune response to infection. Several studies have shown in vitro that functional 51 outwardly rectifying K+ channels are necessary for macrophage activation and 52 production of TNF⍺ 5, 6 , for activation of the NALP inflammasome 7 , for the activation 53 of T helper cells, and the formation of T regulatory cells [8] [9] [10] . The K+ content of the 54 RBC also has a large effect on intra-erythrocytic Plasmodium. It has been shown that 55 an outwardly directed K+ gradient is needed for normal parasite growth and 56 maintenance of the parasite plasma membrane potential [11] [12] [13] . 57
58
A mouse line expressing an activated form of K-Cl co-transporter type 1 (KCC1), 59
discovered from a large scale ENU mutagenesis screen in mice, has recently been 60 
68
Here we use the Kcc1 M935K mouse line to investigate the effect of increased host K+ 69 efflux on susceptibility to malaria infection. When Kcc1 M935K mice were infected with 70
Plasmodium berghei, they showed protection from the development of experimental 71 cerebral malaria (ECM), associated with a significant increase in CD4+ T cells and 72 TNF⍺ in the brain during infection, suggesting K+ efflux through KCC1 alters theinflammatory response to infection. This is the first description of a cation co-74 transporter affecting the development of ECM in mice. 75
76

Results
78
Kcc1
M935K mice are protected against P. berghei infection 79
M935K/M935K mice were inoculated with P. berghei to determine their resistance to 80 parasitic infection. Cumulative survival and peripheral parasitemia were monitored 81 daily over the course of infection. When mice were infected with 1x10 4 P. berghei 82 parasitized red cells, survival was significantly increased in the mutants, with 100% 83 of homozygotes surviving past day 10 of infection, compared to 7% of WT females 84 (P=0.0004; Figure 1A ), and 11% of WT males (P < 0.0001; Figure1B). Significantly 85 lower parasitemia was observed in both Kcc1 M935K females and males. In females, 86 parasitemia was reduced by 63% on day 7, 48% on day 8, and 42% compared to WT, 87 on day 9 post inoculation. Parasitemia in males was similarly reduced, by 66%, 41%, 88 and 53% respectively . 89
90
To determine if this reduction in parasitemia was caused by impairment in the 91 parasite's ability to invade Kcc1 M935K/M935K RBCs and survive within them, we 92 conducted TUNEL staining of infected RBCs to detect fragmented nuclei in the 93 parasites indicative of maturation arrest 15 , and an in vivo invasion and maturation 94 assay as previously described 16 . No significant differences were observed in the 95 TUNEL assay ( Figure 1E ) but a significant 2-fold increase in parasitic growth for 96
Kcc1
M935K/M935K RBCs at 13 hours (P < 0.001) and 21 hours (P < 0.001) ( Figure 1F) In the experiments described above, 90% WT mice succumbed between days 8 and 108 10 post infection. Death at this point in P. berghei infection is usually caused by 109 experimental cerebral malaria (ECM), and unrelated to the level of peripheral 110 parasitemia. Combined with our results from the TUNEL and invasion assays, this 111 hinted that the Kcc1 M935K mutation may not affect parasite growth, but may rather 112 provide more systemic protection from ECM. We therefore infected mice with a dose 113 of P. berghei at which 50% of WT mice survived beyond day 10 of infection. In this 114 experiment Kcc1 M935K/M935K had no difference in survival and no significant 115 differences in parasitemia . This suggests that parasite invasion or 116 maturation is unlikely to be defective in Kcc1 M935K mutant mice. 117
118
Kcc1
M935K promotes resistance to ECM 119
120
To determine if the WT mice were succumbing to P. berghei infection in our 121 challenges resulted from as a result of ECM, mice were injected with P. berghei and 122 symptoms of ECM were scored according to severity, from 0 (no symptoms) to 5(death). Severe clinical symptoms were observed in WT mice, with most dying from 124 seizures, whereas Kcc1 M935K/M935K remained asymptomatic for the length of the 125 experiment ( Figure 2A) . One of the key hallmarks of cerebral malaria is breakdown 126 of the blood brain barrier. Therefore, mice were injected intravenously with Evan's 127
Blue to assess blood brain barrier integrity. Infected WT mice showed an average of 128 14.5±2.9 grams of dye per gram of brain tissue, which was higher than the 8.1±1.4g/g 129 observed in uninfected mice. Infected Kcc1 M935K/M935K more closely resembled 130 uninfected mice, with 9.4 ± 1.3 g/g ( Figure 2B -C). Although none of these differences 131 was significant, the clear trend to higher staining in WT suggested a breakdown of the 132 blood brain barrier that is not observed in Kcc1 M935K/M935K . ECM is also associated 133 with increased sequestration of infected RBCs in the microvasculature. We therefore 134 assayed the relative amount of parasite sequestration in the brain and spleen by PCR 135
M935K/M935K showed a trend to decreased parasitemia in 136 the brain, and increased parasitemia in the spleen ( Figure 2D However we found the presence of hemozoin pigmentation with significant disruption 145 of the neuropil accompanied with white blood cells infiltrations and uninfected RBC 146 infiltrates in the infected WT mice at day 10 post inoculation ( Figure 3B ), whereas 147 this was not observed for infected Kcc1 M935K/M935K mice ( Figure 3D ). Interestingly,pathological examination of the spleen indicates no architectural differences between 149 infected and uninfected Kcc1 M935K/M935K and WT mice ( Figure S1 ) but presence of 150 hemozoin pigmentation in both strains indicates of splenic sequestration ( Figure S1 
Kcc1
M935K/M935K which are more likely to be resistant to the development of this 157 condition, possibly through an increased sequestration of parasites in the spleen, 158 which also aids in preventing iRBC localization to the blood brain barrier. 159
160
Kcc1
M935K display an abnormal immune response to infection 161 162
It has been shown that depletion of CD4+ T cells, CD8+ T cells, and inflammatory 163 monocytes can prevent the development of ECM [17] [18] [19] . ECM resistance is also 164 observed in mice with impaired thymic development of CD8+ T cells 20 . Since the 165 parasites were present in the brain and KCC1 is expressed ubiquitously 21 , we 166 postulated that the Kcc1 M935K mutation might cause alterations to some of these 167 immune cell populations in the brain resulting in a stimulation of the immune 168 response and impairment of parasite growth or increase clearance of the parasites. 169 Therefore, the relative amounts of CD4+ and CD8+ T cells were measured by flow 170 cytometry in the brain, blood, spleen, and thymus, both in uninfected mice, and the 171 day the mice succumbed to ECM, where the inflammatory response is expected to be 172 M935K/M935K showed a significant 1.7-fold 201 increase in the average TNF⍺ concentration in the brain (5723 pg/ml compared to 202 3329 pg/ml) and blood (2503 pg/ml compared to 1504 pg/ml) with a respective p-203 value of 0.0068 in the brain and 0.0134 in the blood ( Figure 5A ), as well as a trend to 204 increased IL-1 in the brain ( Figure 5B ). There were no differences in IFN-γ in 205 either the brain or blood at this time-point ( Figure 5C ). By CBA array, 206
Kcc1
M935K/M935K showed no difference in plasma cytokine levels early in infection; 207 however, a 60% reduction in the amount of IFN--γ, and a 75% reduction in IL--6 208 were observed on day 9 of infection (391pg/ml compared to 969 pg/ml, and 209 2.4pg/ml compared to 10.3pg/ml respectively). This was followed by an 85% 210 reduction in the amount of IL-10 on day 10 of infection (an average of 8pg/ml in 211
M935K compared to 55pg/ml in WT) ( Figure S3 ). A slight increase in the 212 amount of TNF⍺ (P=0.040) was also observed on day 7 ( Figure S3 This study provides the first evidence that host KCC1 plays a role in malaria 221 resistance. It shows that over-activation of the transporter is likely to provideprotection to experimental cerebral malaria (ECM) in P. berghei infection. This is the 223 first description of a mutation in a cation transporter that has an effect on ECM; other 224 previously discovered genes have directly involved host cytokines, antigen 225 presentation 28,29 , or erythrocyte membrane proteins [30] [31] [32] . 226
227
Despite the fact that Kcc1 M935K/M935K showed significantly lower parasitemia than WT 228 during the first 10 days of infection, the mutation did not appear to have a cell 229 autonomous effect on parasite invasion and survival within the RBC. One possible 230 explanation for this observation is suggested by the fact that P. berghei infected 231
RBCs have the ability to cytoadhere to the endothelium of blood vessels. Lower 232 levels of sequestration in the mutants would leave more late stage parasites vulnerable 233 to splenic clearance, and therefore result in reduced parasite burden 33 . Reduced 234 sequestration would also be consistent with protection from cerebral malaria, as 235 infected cells would be less likely to adhere within the microvasculature of the brain. K+ efflux can alter cellular cytokine production [5] [6] [7] ; can increase assembly of the 247 NALP inflammasome in response to pathogen associated proteins 7 ; and is essential 248 for macrophage migration 34 . All of these may contribute to both T cell migration, and 249 the increased IL-1β and TNF-α observed in KCC1 M935K mice. 250
The increase of pro-inflammatory cytokines in the brains of KCC1 M935K mice was 251 surprising, as increased TNF-α have previously been associated with more severe CM 252 (reviewed in 35, 36 ). However, it has been shown that neither TNF-α knock-out, or 253 neutralization with antibodies, is sufficient to prevent CM 37, 38 , suggesting that the 254 soluble cytokine is not itself causative of the condition. Although we did not find any 255 significant differences in IFN-γ in the brains of KCC1 M935K mice at our single time 256 point, we did observe a significant reduction in the plasma two days later than the 257 significant increase in TNF-α. Interestingly, both IFN-γ knock-out and neutralization 258 with antibodies, does protect against ECM (reviewed in 39 ). It may therefore be that 259 the KCC1 M935K mutation does not protect by modulation of any one cytokine, but by a 260 better ability to quickly reduce inflammation after its initial peak. 261
262
Here we have shown that activation of KCC1 is likely to provide protection to 263
P. berghei by preventing the development of experimental cerebral malaria (ECM). 264
This is the first description of a mutation in a transporter that has an effect on ECM. Uninfected, P.berghei infected mice and control were humanely euthanized. The 293 brain was transcardially perfused by with 10 ml of 0.1M ice cold phosphate buffered 294 saline solution (PBS) followed by 10 ml of ice cold 4% paraformaldehyde (PFA) and 295 fixed into 70% ethanol. Brains and spleens from 5 mice from each group were seriallysectioned and stained with Hematoxilyn and Eosin (H&E). Brain and spleen sections 297 were independently examined from 2 different pathologists. 298
Thin tail smears from P. berghei infected mice were fixed in 100% MeOH, and 299 stained with an APO-BrdU TUNEL assay kit according to the manufacturer's 300 instructions (Invitrogen, Carlsbad, CA). Slides were examined on an upright 301 epifluorescence microscope (ZIESS) 600x magnification. 10 fields of view were 302 counted for each slide. per gram brain tissue was calculated using a standard curve ranging from 40µg/ml to 312 0µg/ml. Injections were carried out on the day of infection that the first mouse died. 313
314
Clinical Score 315
Mice were monitored three times daily, and given a score from 0 to 5 based on the 316 type and severity of their symptoms. '0' indicated no symptoms; '1' reduced or 317 languid movement; '2' rapid breathing and/or hunched posture; '3' ruffled fur, 318 dehydration and/or external bleeding; '4' fitting and/or coma; '5' death. Mice were 319 considered comatose if they were unable to right themselves after being placed on 320 their side. The highest score recorded for each mouse on each day was used to 321 generate daily averages. 322
323
Cytokines 324
Peripheral blood was taken either by cardiac puncture or mandibular bleed in a 325 microcentrifuge tube coated with anticoagulants and centrifuged for 4 minutes at 326 11,000xg. Plasma was then taken into a separate tube and stored at -20°C until needed. 327
Cytokine analysis was conducted on un-diluted plasma using a CBA Mouse 328
Th1/Th2/Th17 Cytokine Kit to the maker's instructions (BD biosciences). 329
330
Lymphocyte and Infected Red Blood Cell Analysis 331
Peripheral blood was taken either by cardiac puncture or mandibular bleed, and 332 lymphocytes were isolated on Ficoll-Paque™ according to the maker's instructions. 333
Lymphocytes were then incubated with Fc-block in MT-FACS for 10 minutes at 4°C. 334
335
Both spleen and thymus were prepared for flow cytometry using the same method.
1 ⁄ 2 336 of each organ was passed through a 70µm BD Falcon Cell Strainer with 0.5 ml of 337 MT-FACS buffer, and then centrifuged at 300xg for 5 minutes at 4°C. The 338 supernatant was removed and the pellet re-suspended in 5 ml cold MT-FACS buffer. 
18s PCR from Brain, Spleen and Blood 368
Brain samples were processed as described above. The spleen was also passed 369 through a 70µm BD Falcon Cell Strainer and resuspended to a total volume of 1.5ml 370 in PBS. 371 372 These cells were then centrifuged at 1500xg for 2 minutes at 4°C, and the supernatant 373 was collected for ELISA (methods below). The pellet was resuspended to a total of 374 800µl and split in two, with 400µl taken for PCR, and 400µl snap frozen. Peripheral 375 blood was collected using a cardiac puncture, and centrifuged at 1500xg 10 minutes at 376 4°C. The supernatant was taken for ELISA (below) and the pellet was lysed using two 377 volumes of 0.15% saponin in PBS for 30 minutes at 37°C. Brain and spleen samples 378 were processed similarly in order to successfully lyse any iRBC. The samples were 379 then centrifuged at 10 000xg for 10 minutes at 4°C, and the pellet was washed three 380 times with ice cold PBS. Following this, all samples were processed using the Qiagen 381 DNeasy Blood and Tissue kit with following the manufacturer's instructions. The 382 quality and yield of DNA was quantified using a NanoDrop spectrophotometer. 
CAGACCTGTTGTTGCCTTAAAC; Reverse: GCTTGCGGCTTAATTTGACTC). 387
The reaction parameters for GAPDH were as follows, 95°C for 5 minutes before 35 388 cycles of 95°C 30 seconds, 50°C 30 seconds, 72°C 1 minute, and a final extension at 389 72°C 2minutes. Since the genome of P. berghei is AT rich, the PCR protocol for 18s 390 was 95°C 5 minutes, before 35 cycles of 95°C for 30 seconds, 50°C for 1 minute, 391 68°C for 2 minutes, and a final extension of 68°C for 5 minutes. These reactions were 392 then eletrophoresed on a 1% agarose gel, and imaged using a Bio-Rad Gel Doc™ 393 XR+ Gel Documentation System. Densitometry analysis was conducted on these 394 bands using ImageJ software, and standardized to GAPDH densitometry analysis. 395 Samples were processed as described above, with the supernatants removed and saved 398 for ELISA. ELISAs were conducted following the manufacturers' protocols, with the 399 IL-1b and IFN-y (ELISAKIT.com, EK-0033 and EK-0002, respectively) and TNF-a 400 (ThermoFisher Scientific KMC4022). Samples were diluted 1 in 5 and 1 in 10 for IL-401 1b; 1 in 4 and 1 in 8 for IFN-y, and 1 in 10 and 1 in 20 for TNF-α. The pdata was 402 collected using a Tecan M200 plate reader. 403 404 405
In-vivo Invasion Assay 406
Blood from Mutant and WT uninfected mice was collected by cardiac puncture. 1800 407 μl of blood was collected and pooled for each genotype, then halved and stained with 408 
